The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...
A new study found that fixing energy balance in the brain reversed symptoms of advanced Alzheimer’s in mice. Researchers ...
You think you’re fine. Your family and friends think you’re fine. But, just maybe, you’re not. Maybe you already have Alzheimer’s disease, but you just don’t know it yet, because it can begin ...
The good news at the end of the year was that the FDA approved a pill form of the company's GLP-1 weight loss medication. The ...
Adherence to a structured lifestyle intervention was nonsuperior to a self-guided intervention regarding impact on ...
The FDA gave priority review to an application seeking approval of AXS-05 for Alzheimer's-related agitation, with a decision ...
"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...
Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali’s TransportVehicle™ (TV)-enabled investigational therapy for Hunter syndromeExpecting multiple clinical data readouts from ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
A recent study and some newly approved medications are showing some forward progress in the battle against Alzheimer’s Disease. South Dakota Alzheimer’s Association Executive Director Leslie Morrow ...
A mini-review in Brain Medicine examines the distinct and often opposing roles of AMPKα1 and AMPKα2 isoforms in Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback